Clinical trials
Risk Stratification clinical trials
Below are recruiting risk stratification clinical trials, each written for real people, not researchers. We’re tracking 65 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02741349Recruiting
Checking stroke and bleeding risks in atrial fibrillation
This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.
ParisAges 18 years+ - NCT07400835Recruiting
Using DNA markers to find endometrial cancer in postmenopausal bleeding
This trial tests whether DNA changes in urine, vaginal, or cervical samples can help find endometrial cancer earlier in women with postmenopausal bleeding. If you are having tests for this bleeding, your samples could help improve detection.
Aarhus NAges Any age - NCT07418099Recruiting
Study on a blood test for prolonged clotting time
This study looks at a special blood test (clot waveform analysis) to see if it can help doctors better understand why some people have a prolonged clotting time. This might help them find the cause more quickly and accurately.
Leganés, MadridAges Any age - NCT07480915Recruiting
Heart failure risk after bypass surgery
This study looks at how to predict major heart problems in people with heart failure who are scheduled for bypass surgery (CABG). It aims to improve risk assessment before the procedure.
Tomsk, Tomsk OblastAges Any age - NCT07577609Recruiting
AI-assisted CT scan to assess heart artery disease risk
This study uses artificial intelligence to analyze your heart CT scan and better predict your risk of coronary artery disease (narrowing of the arteries that supply your heart). The goal is to help doctors identify who might need earlier treatment or more careful monitoring.
GalwayAges 18 years+ - NCT07587268Recruiting
Understanding Your Appendiceal Cancer Through Genetic Testing
This research study uses genetic and molecular testing on archived tumor samples to better understand appendiceal cancer and predict how it may progress. The goal is to help doctors personalize treatment plans based on the specific characteristics of your cancer.
Duarte, CaliforniaAges 18 years+ - NCT07618078Recruiting
Personalized Cancer Risk Assessment for Nasopharyngeal Cancer
This study helps doctors predict which patients with nasopharyngeal cancer (a cancer of the upper throat) will benefit most from additional chemotherapy after radiation treatment. It uses a special blood test and imaging to create a personalized risk score for each patient.
Beijing, Beijing MunicipalityAges 18–75 - NCT07647497Recruiting
Heart Imaging to Predict Outcomes in Pulmonary Embolism
This study uses ultrasound images of your heart to see how well the right side is working in people who have a blood clot in the lungs. The goal is to better predict which patients might be at higher risk and need more intensive care.
SohagAges 18 years+ - NCT07667673Recruiting
Heart imaging study for pulmonary arterial hypertension
This study uses heart imaging tests to better understand pulmonary arterial hypertension (PAH) and predict outcomes. It may help doctors tailor treatment for people with PAH.
IstanbulAges 18 years+ - NCT06944353Enrolling by invitation
Fatty liver risk screening in the emergency department
This study looks at fatty liver findings on emergency department scans. If you have fatty liver and were sent home from the ED, the study may help connect you to follow-up care and avoid future liver problems.
Chicago, IllinoisAges 18 years+ - NCT06065761Enrolling by invitation
Better risk assessment for heart failure in the ER
This trial looks at ways to better understand how serious heart failure is for people who come to the emergency room. It could help doctors decide on the best treatment more quickly.
Antioch, CaliforniaAges 18 years+ - NCT05983172Enrolling by invitation
Genomic risk study for new AML patients
This study uses advanced genetic analysis to better understand risk in people newly diagnosed with acute myeloid leukemia (AML) at a specific hospital. It may help tailor future treatments.
TaipeiAges 18 years+ - NCT05979870Enrolling by invitation
AI-enhanced heart MRI for valve disease
This study uses artificial intelligence to improve MRI scans for people with aortic or pulmonary valve disease who are scheduled for valve surgery or a non-surgical valve procedure. It aims to help doctors better assess heart function before treatment.
Gothenburg, GothenburgAges 1 week–18 years - NCT05418959Enrolling by invitationPhase 1
Genetic study to better assess kids’ unusual skin spots
This Phase 1 study looks at genetic risk factors in children with unusual skin lesions. The goal is to help doctors better decide which spots should be closely watched or safely biopsied.
Boston, MassachusettsAges birth–20 years - NCT06296732Recruiting
Keyhole surgery for childhood neuroblastoma
This study looks at using keyhole (laparoscopic) surgery to remove neuroblastoma tumors in children. It groups tumors by risk factors to see which children can safely have this less invasive surgery.
MoscowAges 1 day–18 years - NCT06962488Recruiting
Personalized blood pressure care using genetic risk
This study uses your genetic information (a polygenic risk score) to guide personalized blood pressure management. It aims to help people with high blood pressure and overall poor heart health improve their levels through tailored advice.
Birmingham, AlabamaAges 18–55 - NCT06612944RecruitingPhase 2
Preventing relapse after stem cell transplant for high-risk MDS
This trial tests whether giving medication after a donor stem cell transplant can prevent the return of very high-risk myelodysplastic syndrome (MDS). It is for people who have a suitable donor and are healthy enough for the procedure.
ShanghaiAges 18–70
Hear when a new Risk Stratification trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for risk stratification?
- Yes. Clin2 currently lists 65 recruiting risk stratification studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a risk stratification trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a risk stratification trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.